U.S. markets close in 37 minutes
  • S&P 500

    4,457.22
    +8.24 (+0.19%)
     
  • Dow 30

    34,820.04
    +55.22 (+0.16%)
     
  • Nasdaq

    15,041.63
    -10.61 (-0.07%)
     
  • Russell 2000

    2,251.22
    -7.82 (-0.35%)
     
  • Crude Oil

    73.92
    +0.62 (+0.85%)
     
  • Gold

    1,746.90
    -2.90 (-0.17%)
     
  • Silver

    22.34
    -0.34 (-1.49%)
     
  • EUR/USD

    1.1719
    -0.0028 (-0.23%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • GBP/USD

    1.3667
    -0.0054 (-0.39%)
     
  • USD/JPY

    110.7800
    +0.4790 (+0.43%)
     
  • BTC-USD

    42,285.48
    -2,513.16 (-5.61%)
     
  • CMC Crypto 200

    1,051.76
    -51.30 (-4.65%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     

What You Need To Know About ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Investor Composition

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

A look at the shareholders of ClearPoint Neuro, Inc. (NASDAQ:CLPT) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Warren Buffett said that he likes "a business with enduring competitive advantages that is run by able and owner-oriented people." So it's nice to see some insider ownership, because it may suggest that management is owner-oriented.

ClearPoint Neuro is a smaller company with a market capitalization of US$381m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that institutions are noticeable on the share registry. We can zoom in on the different ownership groups, to learn more about ClearPoint Neuro.

See our latest analysis for ClearPoint Neuro

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About ClearPoint Neuro?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that ClearPoint Neuro does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of ClearPoint Neuro, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

We note that hedge funds don't have a meaningful investment in ClearPoint Neuro. PTC Therapeutics, Inc. is currently the largest shareholder, with 6.2% of shares outstanding. For context, the second largest shareholder holds about 5.2% of the shares outstanding, followed by an ownership of 3.2% by the third-largest shareholder. In addition, we found that Joseph Burnett, the CEO has 1.1% of the shares allocated to their name.

On studying our ownership data, we found that 25 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.

Insider Ownership Of ClearPoint Neuro

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

It seems insiders own a significant proportion of ClearPoint Neuro, Inc.. Insiders have a US$49m stake in this US$381m business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

General Public Ownership

The general public holds a substantial 60% stake in ClearPoint Neuro, suggesting it is a fairly popular stock. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

Public Company Ownership

We can see that public companies hold 6.2% of the ClearPoint Neuro shares on issue. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - ClearPoint Neuro has 2 warning signs we think you should be aware of.

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.